Passage BIO PASG
NASDAQ PASG
$3.85 -0.15 (-3.87%)
As of: Nov 12, 2026 · 1:52 PM EST

Passage BIO (PASG) Sales of Property, Plant and Equipment (2021 - 2026)

Updated

Passage BIO (PASG) posted Sales of Property, Plant and Equipment of $20,000 for Q1 2026, down 96.6% from $585,000 a year earlier.

Analysis

Passage BIO (PASG) Sales of Property, Plant and Equipment (2021 - 2026) Analysis & Trends

For FY2025, Passage BIO's Sales of Property, Plant and Equipment came in at $1.17 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Passage BIO 12.16 Mn -111.84 Mn - 3,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3,000.00
Mar 31, 2026 20,000.00
Jun 30, 2025 585,000.00
Mar 31, 2025 585,000.00
Mar 31, 2021 2.77 Mn
API Access

Passage BIO Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=PASG&period=max&api_key=YOUR_API_KEY